119 related articles for article (PubMed ID: 12878063)
1. [Medullary thyroid carcinomas: persistent hypercalcitoninemia after surgery, reoperations-results].
Proye C
Ann Chir; 2003 Jun; 128(5):289-92. PubMed ID: 12878063
[TBL] [Abstract][Full Text] [Related]
2. [Detection of residual lesions and metastases of medullary thyroid cancer].
Murat A
Ann Endocrinol (Paris); 1996; 57(1):27-32. PubMed ID: 8734286
[TBL] [Abstract][Full Text] [Related]
3. Biochemical results of reoperations for medullary thyroid carcinoma.
Fernandez Vila JM; Peix JL; Mandry AC; Mezzadri NA; Lifante JC
Laryngoscope; 2007 May; 117(5):886-9. PubMed ID: 17473689
[TBL] [Abstract][Full Text] [Related]
4. Surgical management and follow-up of medullary thyroid carcinoma.
Marzano LA; Porcelli A; Biondi B; Lupoli G; Delrio P; Lombardi G; Zarrilli L
J Surg Oncol; 1995 Jul; 59(3):162-8. PubMed ID: 7609522
[TBL] [Abstract][Full Text] [Related]
5. Surgical strategy for the treatment of sporadic medullary thyroid carcinoma: our experience.
Lupone G; Antonino A; Rosato A; Zenone P; Iervolino EM; Grillo M; De Palma M
G Chir; 2012; 33(11-12):395-9. PubMed ID: 23140924
[TBL] [Abstract][Full Text] [Related]
6. Review analysis of medullary carcinoma of the thyroid: a 15-year Indian experience.
Dorairajan N; Siddharth D; Kanna S
Int Surg; 2006; 91(3):162-7. PubMed ID: 16845858
[TBL] [Abstract][Full Text] [Related]
7. Rationale for central and bilateral lymph node dissection in sporadic and hereditary medullary thyroid cancer.
Scollo C; Baudin E; Travagli JP; Caillou B; Bellon N; Leboulleux S; Schlumberger M
J Clin Endocrinol Metab; 2003 May; 88(5):2070-5. PubMed ID: 12727956
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of reoperations for medullary thyroid carcinoma.
Fialkowski E; DeBenedetti M; Moley J
World J Surg; 2008 May; 32(5):754-65. PubMed ID: 18188643
[TBL] [Abstract][Full Text] [Related]
9. Reoperation for recurrent or persistent medullary thyroid cancer.
Moley JF; Wells SA; Dilley WG; Tisell LE
Surgery; 1993 Dec; 114(6):1090-5; discussion 1095-6. PubMed ID: 8256212
[TBL] [Abstract][Full Text] [Related]
10. Medullary thyroid carcinoma: genetic advances, treatment recommendations, and the approach to the patient with persistent hypercalcitoninemia.
Chi DD; Moley JF
Surg Oncol Clin N Am; 1998 Oct; 7(4):681-706. PubMed ID: 9735129
[TBL] [Abstract][Full Text] [Related]
11. A Nationwide Study of Multiple Endocrine Neoplasia Type 2A in Norway: Predictive and Prognostic Factors for the Clinical Course of Medullary Thyroid Carcinoma.
Opsahl EM; Brauckhoff M; Schlichting E; Helset K; Svartberg J; Brauckhoff K; Mæhle L; Engebretsen LF; Sigstad E; Grøholt KK; Akslen LA; Jørgensen LH; Varhaug JE; Bjøro T
Thyroid; 2016 Sep; 26(9):1225-38. PubMed ID: 27400880
[TBL] [Abstract][Full Text] [Related]
12. [Reoperation of medullary thyroid carcinoma: long-term results].
Tamagnini P; Bernante P; Piotto A; Toniato A; Pelizzo MR
Ann Chir; 2001 Oct; 126(8):762-7. PubMed ID: 11692761
[TBL] [Abstract][Full Text] [Related]
13. Persistent hypercalcitoninemia in patients with medullary thyroid cancer.
Misso C; Calzolari F; Puxeddu E; Lucchini R; Monacelli M; Giammartino C; Sanguinetti A; d'Ajello M; Ragusa M; Avenia N
Tumori; 2009; 95(4):484-7. PubMed ID: 19856661
[TBL] [Abstract][Full Text] [Related]
14. Medullary thyroid cancer.
Kebebew E; Clark OH
Curr Treat Options Oncol; 2000 Oct; 1(4):359-67. PubMed ID: 12057161
[TBL] [Abstract][Full Text] [Related]
15. Determinative factors of biochemical cure after primary and reoperative surgery for sporadic medullary thyroid carcinoma.
Gimm O; Ukkat J; Dralle H
World J Surg; 1998 Jun; 22(6):562-7; discussion 567-8. PubMed ID: 9597929
[TBL] [Abstract][Full Text] [Related]
16. Long-Term Follow-up in Medullary Thyroid Carcinoma.
Raue F; Frank-Raue K
Recent Results Cancer Res; 2015; 204():207-25. PubMed ID: 26494391
[TBL] [Abstract][Full Text] [Related]
17. Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach.
Byeon HK; Holsinger FC; Tufano RP; Chung HJ; Kim WS; Koh YW; Choi EC
Ann Surg Oncol; 2014 Nov; 21(12):3872-5. PubMed ID: 25227305
[TBL] [Abstract][Full Text] [Related]
18. Long-term results of reoperation and localizing studies in patients with persistent or recurrent medullary thyroid cancer.
Kebebew E; Kikuchi S; Duh QY; Clark OH
Arch Surg; 2000 Aug; 135(8):895-901. PubMed ID: 10922248
[TBL] [Abstract][Full Text] [Related]
19. [Results of selective venous site-specific catheterization in occult C-cell carcinoma of the thyroid gland].
Cupisti K; Simon D; Dotzenrath C; Goretzki PE; Röher HD
Langenbecks Arch Chir; 1997; 382(6):295-301. PubMed ID: 9498199
[TBL] [Abstract][Full Text] [Related]
20. Biochemical cure after reoperations for medullary thyroid carcinoma: a meta-analysis.
Rowland KJ; Jin LX; Moley JF
Ann Surg Oncol; 2015 Jan; 22(1):96-102. PubMed ID: 25234024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]